R U OK? The Acceptability and Feasibility of New Communication Technologies for Follow-up After Medical Abortion
NCT ID: NCT01362387
Last Updated: 2013-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
999 participants
INTERVENTIONAL
2011-04-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: The use of "alternative" methods to assess outcomes after early medical abortion will achieve a higher rate of follow-up than women undergoing "standard" follow-up
Primary aim: To determine the follow-up rate after early medical abortion with an alternative protocol as compared to a standard follow-up protocol
Secondary aims:
* To assess complication rates and receipt of further treatment among women in the two study arms
* To ascertain women's preferences for mode of communication regarding their post-medical abortion status
* To determine provider opinions and preferences for different follow-up modalities
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medication Abortion With Autonomous Self-Assessment Project
NCT05278780
Home Follow-up After Medication Abortion
NCT04304365
Medication Abortion for Pregnancy of Unknown Location
NCT04026789
Choice of Modality of Follow up for Medication Abortion
NCT04056637
A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks
NCT02720991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Women assigned to Group 1 will receive the standard post-abortion follow-up currently used at bpas and will be undertaken as usual by staff at the treating clinic
No interventions assigned to this group
Group 2
Follow-up after medical abortion using a standard text message, online or telephone questionnaire and a low sensitivity urine pregnancy test.
Alternative follow-up protocol
Women (n=1000) will be allocated by chance to one of two groups: alternative follow-up using a standard text message, online or telephone questionnaire and a low sensitivity urine pregnancy test, or standard follow-up which consists of an in person visit with an ultrasound or a telephone call and high sensitivity pregnancy test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alternative follow-up protocol
Women (n=1000) will be allocated by chance to one of two groups: alternative follow-up using a standard text message, online or telephone questionnaire and a low sensitivity urine pregnancy test, or standard follow-up which consists of an in person visit with an ultrasound or a telephone call and high sensitivity pregnancy test.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* eligible for an abortion under the terms of the Abortion Act (1967),
* requesting an early medical abortion,
* willing and able to comply with the study protocol and visit schedule,
* access to either a mobile phone, intranet or telephone and willing to have communication by one of these means to assess post-medical abortion status,
* willing to have call back messages left,
* willing and able to provide valid informed consent, and
* able to communicate in English.
Exclusion Criteria
* current participation in another research study that, in the opinion of the investigator, would interfere with the conduct of this study.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Pregnancy Advisory Service
OTHER
Gynuity Health Projects
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hillary Bracken, PhD
Role: PRINCIPAL_INVESTIGATOR
Gynuity Health Projects
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham Day Care Unit
Birmingham, , United Kingdom
Chester Day Care Unit
Chester, , United Kingdom
London Central Day Care Unit
London, , United Kingdom
Luton Day Care Unit
Luton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1.4.3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.